GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Simris Alg AB (OSTO:SIMRIS B) » Definitions » Tariff Resilience Score

Simris Alg AB (OSTO:SIMRIS B) Tariff Resilience Score : 0/10 (As of Jun. 28, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Simris Alg AB Tariff Resilience Score?

Simris Alg AB has the Tariff Resilience Score of 0, which implies that the company might have .

Simris Alg AB has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Simris Alg AB might have .


Simris Alg AB  (OSTO:SIMRIS B) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Simris Alg AB Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of Simris Alg AB's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Simris Alg AB Business Description

Traded in Other Exchanges
N/A
Address
Herrestadsvagen 24A, Hammenhog, SWE, 276 50
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.

Simris Alg AB Headlines

No Headlines